JP Morgan Chase
BBH icon

JP Morgan Chase’s VanEck Biotech ETF BBH Stock Holding History

JP Morgan Chase’s Portfolio BBH Stock Details BBH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$743K Buy
4,059
+1,857
+84% +$358K ﹤0.01% 4770
2025
Q4 		$417K Sell
2,202
-614
-22% -$114K ﹤0.01% 5142
2025
Q3 		$467K Sell
2,816
-1,480
-34% -$241K ﹤0.01% 5079
2025
Q2 		$658K Sell
4,296
-3,044
-41% -$453K ﹤0.01% 4633
2025
Q1 		$1.15M Sell
7,340
-2,921
-28% -$474K ﹤0.01% 4246
2024
Q4 		$1.61M Sell
10,261
-1,811
-15% -$305K ﹤0.01% 4308
2024
Q3 		$2.14M Sell
12,072
-2,773
-19% -$492K ﹤0.01% 3954
2024
Q2 		$2.5M Sell
14,845
-66,444
-82% -$10.9M ﹤0.01% 3587
2024
Q1 		$13.5M Buy
81,289
+3,477
+4% +$576K ﹤0.01% 2214
2023
Q4 		$12.9M Buy
77,812
+18,266
+31% +$2.81M ﹤0.01% 2225
2023
Q3 		$9.27M Sell
59,546
-7,354
-11% -$1.17M ﹤0.01% 2324
2023
Q2 		$10.4M Buy
66,900
+5,598
+9% +$894K ﹤0.01% 2256
2023
Q1 		$9.94M Sell
61,302
-12,841
-17% -$2.08M ﹤0.01% 2292
2022
Q4 		$11.8M Sell
74,143
-1,436
-2% -$227K ﹤0.01% 2101
2022
Q3 		$10.6M Sell
75,579
-1,852
-2% -$280K ﹤0.01% 2106
2022
Q2 		$11.3M Buy
+77,431
New +$11.5M ﹤0.01% 2048
2021
Q3 		– Sell
-17
Closed -$3K – 6472
2021
Q2 		$3K Hold
17
– – ﹤0.01% 6171
2021
Q1 		$3K Hold
17
– – ﹤0.01% 5899
2020
Q4 		$3K Hold
17
– – ﹤0.01% 5485
2020
Q3 		$3K Hold
17
– – ﹤0.01% 5353
2020
Q2 		$3K Hold
17
– – ﹤0.01% 5227
2020
Q1 		$2K Sell
17
-78
-82% -$10.5K ﹤0.01% 5177
2019
Q4 		$13K Hold
95
– – ﹤0.01% 5366
2019
Q3 		$11K Hold
95
– – ﹤0.01% 5491
2019
Q2 		$12K Hold
95
– – ﹤0.01% 5532
2019
Q1 		$12K Hold
95
– – ﹤0.01% 5507
2018
Q4 		$11K Hold
95
– – ﹤0.01% 5416
2018
Q3 		$13K Hold
95
– – ﹤0.01% 5474
2018
Q2 		$11K Hold
95
– – ﹤0.01% 5359
2018
Q1 		$11K Hold
95
– – ﹤0.01% 5152
2017
Q4 		$12K Sell
95
-34
-26% -$4.34K ﹤0.01% 5235
2017
Q3 		$17K Sell
129
-400
-76% -$52.1K ﹤0.01% 4646
2017
Q2 		$66K Sell
529
-4,198
-89% -$506K ﹤0.01% 4285
2017
Q1 		$563K Sell
4,727
-2,645
-36% -$309K ﹤0.01% 3656
2016
Q4 		$793K Sell
7,372
-1,535
-17% -$167K ﹤0.01% 3546
2016
Q3 		$1.03M Buy
8,907
+201
+2% +$22.9K ﹤0.01% 3123
2016
Q2 		$892K Sell
8,706
-19,855
-70% -$2.12M ﹤0.01% 3224
2016
Q1 		$2.96M Sell
28,561
-6,814
-19% -$711K ﹤0.01% 2502
2015
Q4 		$4.49M Buy
35,375
+31,943
+931% +$3.91M ﹤0.01% 2287
2015
Q3 		$392K Buy
3,432
+151
+5% +$20K ﹤0.01% 3510
2015
Q2 		$442K Buy
3,281
+323
+11% +$42.9K ﹤0.01% 3599
2015
Q1 		$383K Buy
+2,958
New +$372K ﹤0.01% 3635

Other funds holding BBH

Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
Raymond James Financial
Raymond James Financial St Petersburg, Florida $324B AUM 22.36% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
MIM
Miller Investment Management West Conshohocken, Pennsylvania $1.01B AUM 13.96% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return
LPL Financial
LPL Financial San Diego, California $377B AUM 19.32% 1-Year Est. Return
CCA
Conservest Capital Advisors Wynnewood, Pennsylvania $1.1B AUM 16.5% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
BFG
Bleakley Financial Group Fairfield, New Jersey $6.39B AUM 26.33% 1-Year Est. Return

JP Morgan Chase's BBH Position: Q1 2026 in Review

JP Morgan Chase increased its VanEck Biotech ETF (BBH) stake by 84% in Q1 2026, buying an estimated $358K and bringing the position to 4,059 shares worth $743K. The position accounts for ﹤0.01% of the portfolio, ranked #4770.

JP Morgan Chase first reported a position in BBH in Q1 2015 and has held it in 42 quarters since. The position peaked at $13.5M in Q1 2024. 112 funds tracked by Wall St. Rank hold BBH as of Q1 2026.

  • JP Morgan Chase held 4,059 shares of VanEck Biotech ETF worth $743K as of Q1 2026.
  • JP Morgan Chase bought 1,857 VanEck Biotech ETF shares in Q1 2026, an estimated $358K.
  • VanEck Biotech ETF made up ﹤0.01% of JP Morgan Chase's portfolio in Q1 2026, its #4770 holding.
  • JP Morgan Chase first reported a position in VanEck Biotech ETF in Q1 2015 and has held it in 42 quarters since.
  • JP Morgan Chase's VanEck Biotech ETF position peaked at $13.5M in Q1 2024.
  • 112 funds tracked by Wall St. Rank held VanEck Biotech ETF as of Q1 2026.

Based on JP Morgan Chase's 13F filing for Q1 2026, filed 13 May 2026.